Boerhinger funds ADA initiative

Share this article:

Boehringer Ingelheim is sponsoring a collaborative research project with the American Diabetes Association to improve the evidence base for and clinical care of patients with chronic kidney disease and diabetes.

The three-year commitment includes $1.5 million from Boehringer, which will be managed by the ADA.

“Diabetes is the leading cause of kidney failure, accounting for more than 40% of new cases,” the American Diabetes Association's president of medicine and science Elizabeth Seaquist said in a statement.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.